Tag: Dr. Kishore Iyer
VectivBio begins phase 3 trial of apraglutide in short bowel syndrome
VectivBio has dosed the first patient in its phase 3 STARS clinical trial of its synthetic GLP-2 analog apraglutide in short bowel syndrome (SBS). The ... Read More